We will include healthy people who do not use or people who sometime use allergy medications. We will exclude minors (less than 18 years old), pregnant women, those planning a pregnancy, and lactating women.
Conditions
Interventions
None listed
Sponsors
KAGOME CO., LTD.
Review Team Professor Hiroharu Kamioka, Department of Ecological Symbiotic Science, Tokyo University of Agriculture Ms. Satoko Shindo, Center for Academic Resources, St. Luke'
s International University. Mr. Yudai Aoki, Innovation Division, KAGOME CO., LTD. Dr. Kazutaka Yoshida, Innovation Division, KAGOME CO., LTD. Mr. Shingo Takahashi, Innovation Division, KAGOME CO., LTD.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (Study design) We will include randomized controlled parallel trials (RCT-P), randomized controlled crossover trials (RCT-C), quasi- randomized controlled parallel trials (qRCT-P), quasi- randomized controlled crossover trials (qRCT-C), non-randomized controlled parallel trials (nonRCT-P), non-randomized controlled crossover trials (nonRCT-C), and non-randomized controlled trials. We will include scientific papers and reports which give us enough research details. (PICO) Participant: We will include healthy people who do not use or people who sometime use allergy medications. We will exclude minors (less than 18 years old), pregnant women, those planning a pregnancy, and lactating women. Intervention: We define oral intake of beta-carotene as an intervention. Comparison: We define oral intake of test food not containing beta-carotene, as controls. We also define maintaining daily life as a control. Outcome measurement: We will evaluate nasal markers of comfortability (Japanese allergic rhinitis standard quality of life questionnaire (JRQLQ) and the similar markers in foreign countries) as primary outcome. We will evaluate nasal-ocular and ocular markers of comfortability (JRQLQ and the similar markers in foreign countries) as secondary outcomes. (Language) Eligibility is not restricted by language.
Exclusion criteria
Exclusion criteria: We will exclude proceedings and unpublished studies which don't give us enough research details.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| We will evaluate the effect of beta-carotene intake on the nasal markers of comfortability (Japanese allergic rhinitis standard quality of life questionnaire (JRQLQ) and the similar markers in foreign countries). | — |
Secondary
| Measure | Time frame |
|---|---|
| We will evaluate the effect of beta-carotene intake on the nasal-ocular and ocular markers of comfortability (JRQLQ and the similar markers in foreign countries). | — |
Countries
Japan
Contacts
Public ContactTakuro Inoue
KAGOME CO., LTD. Innovation Division
Outcome results
None listed